ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för (-)-epigallocatechin 3-gallate. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

28 träffar

Bibliografisk träff 2021-09-23

Structural characterization and antioxidant property of enzymatic-transesterification derivatives of (-)-epigallocatechin-3-O-gallate and vinyl laurate.

Jiang C, Wang L, Huang X, Zhu S, Ma C, Wang H.

J Food Sci · journal article · DOI 10.1111/1750-3841.15894

Bibliografisk träff 2021-02-01

(-)-Epigallocatechin-3-O-gallate at a high concentration may induce lipolysis via ATP consumption by activation of stress defense mechanisms.

Suihara S, Ishisaka A, Murakami A.

Biosci Biotechnol Biochem · journal article · DOI 10.1093/bbb/zbaa056

Bibliografisk träff 2020-07-05

Role of Curcumin and (-)-Epigallocatechin-3-<i>O</i>-Gallate in Bladder Cancer Treatment: A Review.

Piwowarczyk L, Stawny M, Mlynarczyk DT, Muszalska-Kolos I, Goslinski T, Jelińska A.

Cancers (Basel) · review-article; review; journal article · DOI 10.3390/cancers12071801

Bibliografisk träff 2020-01-01

Development of High-Order Functions Using (-)-Epigallocatechin-3-O-gallate in Water.

Ishizu T.

Chem Pharm Bull (Tokyo) · review; journal article · DOI 10.1248/cpb.c20-00197

Bibliografisk träff 2019-11-25

Deciphering the molecular specificity of phenolic compounds as inhibitors or glycosyl acceptors of β-fructofuranosidase from Xanthophyllomyces dendrorhous.

Ramirez-Escudero M, Miguez N, Gimeno-Perez M, Ballesteros AO, Fernandez-Lobato M, Plou FJ, Sanz-Aparicio J.

Sci Rep · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-019-53948-y

Bibliografisk träff 2019-09-10

(-)-Epigallocatechin 3-<i>O</i>-Gallate as a New Approach for the Treatment of Visceral Leishmaniasis.

Inacio JDF, Fonseca MS, Almeida-Amaral EE.

J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jnatprod.9b00632

Bibliografisk träff 2013-08-20

The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats.

Niu Y, Na L, Feng R, Gong L, Zhao Y, Li Q, Li Y, Sun C.

Aging Cell · research support, non-u.s. gov't; journal article · DOI 10.1111/acel.12133

Bibliografisk träff 2012-08-02

Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.

Kowalinski E, Zubieta C, Wolkerstorfer A, Szolar OH, Ruigrok RW, Cusack S.

PLoS Pathog · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.ppat.1002831

Bibliografisk träff 2012-01-28

Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.

Lopez del Amo JM, Fink U, Dasari M, Grelle G, Wanker EE, Bieschke J, Reif B.

J Mol Biol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jmb.2012.01.013

Bibliografisk träff 2011-07-12

Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.

Urusova DV, Shim JH, Kim DJ, Jung SK, Zykova TA, Carper A, Bode AM, Dong Z.

Cancer Prev Res (Phila) · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1940-6207.capr-11-0301

Bibliografisk träff 2011-03-24

(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.

Hazawa M, Takahashi K, Sugata S, Kashiwakura I.

J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/np1007729

Bibliografisk träff 2010-11-16

Catechin derivatives from Parapiptadenia rigida with in vitro wound-healing properties.

Schmidt CA, Murillo R, Bruhn T, Bringmann G, Goettert M, Heinzmann B, Brecht V, Laufer SA, Merfort I.

J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/np100523s

Bibliografisk träff 2010-07-01

The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.

Miyata M, Sato T, Kugimiya M, Sho M, Nakamura T, Ikemizu S, Chirifu M, Mizuguchi M, Nabeshima Y, Suwa Y, Morioka H, Arimori T, Suico MA, Shuto T, Sako Y, Momohara M, Koga T, Morino-Koga S, Yamagata Y, Kai H.

Biochemistry · research support, non-u.s. gov't; journal article · DOI 10.1021/bi1004409

Bibliografisk träff 2010-01-01

Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells.

Cheng CW, Shieh PC, Lin YC, Chen YJ, Lin YH, Kuo DH, Liu JY, Kao JY, Kao MC, Way TD.

J Agric Food Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jf903377e

Bibliografisk träff 2009-09-26

Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells.

Qiao Y, Cao J, Xie L, Shi X.

Arch Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s12272-009-1917-3

Bibliografisk träff 2009-06-20

Solution structure of human cardiac troponin C in complex with the green tea polyphenol, (-)-epigallocatechin 3-gallate.

Robertson IM, Li MX, Sykes BD.

J Biol Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1074/jbc.m109.021352

Bibliografisk träff 2009-06-17

Epigallocatechin-3-gallate is an inhibitor of Na+, K(+)-ATPase by favoring the E1 conformation.

Ochiai H, Takeda K, Soeda S, Tahara Y, Takenaka H, Abe K, Hayashi Y, Noguchi S, Inoue M, Schwarz S, Schwarz W, Kawamura M.

Biochem Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2009.06.007

Bibliografisk träff 2009-01-01

(-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor.

Yin Z, Henry EC, Gasiewicz TA.

Biochemistry · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/bi801637q

Bibliografisk träff 2008-12-11

Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stress resistance in Caenorhabditis elegans.

Abbas S, Wink M.

Planta Med · journal article · DOI 10.1055/s-0028-1088378

Bibliografisk träff 2008-09-01

The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.

Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS.

J Nutr · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/jn/138.9.1677

Bibliografisk träff 2008-07-29

Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells.

Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, Hara A, Mori H, Shibata T.

Br J Cancer · research-article; journal article · DOI 10.1038/sj.bjc.6604521

Bibliografisk träff 2006-10-13

Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.

Williamson MP, McCormick TG, Nance CL, Shearer WT.

J Allergy Clin Immunol · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.jaci.2006.08.016

Bibliografisk träff 2005-07-01

Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors.

Mizushina Y, Saito A, Tanaka A, Nakajima N, Kuriyama I, Takemura M, Takeuchi T, Sugawara F, Yoshida H.

Biochem Biophys Res Commun · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbrc.2005.05.093

Bibliografisk träff 2004-03-14

A receptor for green tea polyphenol EGCG.

Tachibana H, Koga K, Fujimura Y, Yamada K.

Nat Struct Mol Biol · research support, non-u.s. gov't; journal article · DOI 10.1038/nsmb743

Bibliografisk träff 2003-11-01

Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS.

Cancer Res · research support, u.s. gov't, p.h.s.; journal article

Bibliografisk träff 2003-10-01

Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.

Brusselmans K, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV.

Int J Cancer · research support, non-u.s. gov't; journal article · DOI 10.1002/ijc.11317

Bibliografisk träff 2003-08-01

Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase.

Rodríguez-Caso C, Rodríguez-Agudo D, Sánchez-Jiménez F, Medina MA.

Cell Mol Life Sci · research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/s00018-003-3135-3

Bibliografisk träff 2002-03-01

Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells.

Takada M, Ku Y, Habara K, Ajiki T, Suzuki Y, Kuroda Y.

World J Surg · journal article · DOI 10.1007/s00268-001-0290-2